You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Before and After: Patient Cases in Onychomycosis

  • Authors: Boni E. Elewski, MD; Bryan D. Caldwell, DPM, MD; Antonella Tosti, MD
  • CME / ABIM MOC / CE Released: 11/22/2017
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 11/22/2018
Start Activity


Target Audience and Goal Statement

This activity is intended for dermatologists, primary care physicians, podiatrists, nurse practitioners, nurses, and physician assistants.

The goal of this activity is to present visual examples of real cases of onychomycosis infection and to discuss individualization of treatment for these patients.

Upon completion of this activity, participants will have greater competence related to:

  • Recognition of onychomycosis infection
  • Diagnostic testing to confirm onychomycosis infection
  • Assessment of treatment effectiveness for onychomycosis


Moderator

  • Boni E. Elewski, MD

    Professor of Dermatology; Chair, Department of Dermatology, University of Alabama at Birmingham

    Disclosures

    Disclosure: Boni E. Elewski, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Celgene Corporation; Lilly; Novartis Pharmaceuticals Corporation; Pfizer Inc; Sun Pharmaceuticals Industries, Ltd.; Valeant Pharmaceuticals International
    Received grants for clinical research from: AbbVie Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Celgene Corporation; Incyte Corporation; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Regeneron Pharmaceuticals, Inc.; Sun Pharmaceuticals Industries, Ltd.; Valeant Pharmaceuticals International; Viamet Pharmaceuticals Holdings, LLC

    Dr Elewski does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Elewski does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Panelists

  • Antonella Tosti, MD

    Professor, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida

    Disclosures

    Disclosure: Antonella Tosti, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Almirall, S.A.; Polichem S.A.; Valeant Pharmaceuticals International; Viamet Pharmaceuticals Holdings, LLC
    Served as a speaker or a member of a speakers bureau for: PharmaDerm

    Dr Tosti does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Tosti does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Bryan D. Caldwell, DPM, MD

    Professor; Assistant Dean, College of Podiatric Medicine, Kent State University, Kent, Ohio

    Disclosures

    Disclosure: Bryan D. Caldwell, DPM, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: PEDiNOL
    Served as a speaker or a member of a speakers bureau for: Janssen Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; PEDiNOL; Pfizer Inc; PharmaDerm; Valeant Pharmaceuticals International

    Dr Caldwell does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Caldwell does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

  • Shari J. Dermer, PhD,

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Shari J. Dermer, PhD , has disclosed no relevant financial relationships.

  • Faith Reidenbach

    Medical Writer

    Disclosures

    Disclosure: Faith Reidenbach, has disclosed no relevant financial relationships.

CME Reviewer / Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.5 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Before and After: Patient Cases in Onychomycosis

Authors: Boni E. Elewski, MD; Bryan D. Caldwell, DPM, MD; Antonella Tosti, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC / CE Released: 11/22/2017

Valid for credit through: 11/22/2018

processing....

 

  • Print